These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24669288)

  • 21. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - challenges and perspectives.
    Polidori MC; Nelles G
    Curr Pharm Des; 2014; 20(18):3083-92. PubMed ID: 24079767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of oxidative stress in the pathogenesis of Alzheimer's disease.
    Filipcik P; Cente M; Ferencik M; Hulin I; Novak M
    Bratisl Lek Listy; 2006; 107(9-10):384-94. PubMed ID: 17262991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of antioxidant therapy for Alzheimer's Disease.
    Pitchumoni SS; Doraiswamy PM
    J Am Geriatr Soc; 1998 Dec; 46(12):1566-72. PubMed ID: 9848820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress in alzheimer's disease: A review on emergent natural polyphenolic therapeutics.
    Cassidy L; Fernandez F; Johnson JB; Naiker M; Owoola AG; Broszczak DA
    Complement Ther Med; 2020 Mar; 49():102294. PubMed ID: 32147039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease.
    Choi DY; Lee YJ; Hong JT; Lee HJ
    Brain Res Bull; 2012 Feb; 87(2-3):144-53. PubMed ID: 22155297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease.
    Mecocci P; Polidori MC
    Biochim Biophys Acta; 2012 May; 1822(5):631-8. PubMed ID: 22019723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.
    Chakrabarti S; Sinha M; Thakurta IG; Banerjee P; Chattopadhyay M
    Curr Med Chem; 2013; 20(37):4648-64. PubMed ID: 23834172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural antioxidants in Alzheimer's disease.
    Mancuso C; Bates TE; Butterfield DA; Calafato S; Cornelius C; De Lorenzo A; Dinkova Kostova AT; Calabrese V
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1921-31. PubMed ID: 18042001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects.
    Wojsiat J; Zoltowska KM; Laskowska-Kaszub K; Wojda U
    Oxid Med Cell Longev; 2018; 2018():6435861. PubMed ID: 29636850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative challenge in Alzheimer's disease: state of knowledge and future needs.
    Cervellati C; Wood PL; Romani A; Valacchi G; Squerzanti M; Sanz JM; Ortolani B; Zuliani G
    J Investig Med; 2016 Jan; 64(1):21-32. PubMed ID: 26755810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible role of antioxidant vitamin C in Alzheimer's disease treatment and prevention.
    Heo JH; Hyon-Lee ; Lee KM
    Am J Alzheimers Dis Other Demen; 2013 Mar; 28(2):120-5. PubMed ID: 23307795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant strategies for Alzheimer's disease.
    Grundman M; Grundman M; Delaney P
    Proc Nutr Soc; 2002 May; 61(2):191-202. PubMed ID: 12133201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant treatment in Alzheimer's disease: current state.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Mol Neurosci; 2003; 21(1):1-11. PubMed ID: 14500988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corydalis edulis total alkaloids (CETA) ameliorates cognitive dysfunction in rat model of Alzheimer disease through regulation of the antioxidant stress and MAP2/NF-κB.
    Liang S; Zheng Y; Lei L; Deng X; Ai J; Li Y; Zhang T; Mei Z; Ren Y
    J Ethnopharmacol; 2020 Apr; 251():112540. PubMed ID: 31917278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements.
    Tadokoro K; Ohta Y; Inufusa H; Loon AFN; Abe K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidants and Alzheimer's disease: from bench to bedside (and back again).
    Rutten BP; Steinbusch HW; Korr H; Schmitz C
    Curr Opin Clin Nutr Metab Care; 2002 Nov; 5(6):645-51. PubMed ID: 12394639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease.
    Dumont M; Stack C; Elipenhali C; Calingasan NY; Wille E; Beal MF
    Neurosci Lett; 2011 Apr; 492(3):150-4. PubMed ID: 21300136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.